查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1990460

傳統髖關節螺絲市場：2026-2032年全球市場預測（按產品類型、材料、手術入路、應用、最終用戶和分銷管道分類）

Conventional Hip Screws Market by Product Type, Material, Surgical Approach, Application, End User, Distribution Channel - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 184 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2025 年傳統髖螺絲市場價值為 4.466 億美元，預計到 2026 年將成長至 4.6995 億美元，複合年成長率為 5.85%，到 2032 年將達到 6.6495 億美元。

主要市場統計數據
基準年 2025 4.466億美元
預計年份：2026年 4.6995億美元
預測年份：2032年 6.6495億美元
複合年成長率 (%) 5.85%

對現代常規髖螺釘在外科手術實踐中的臨床、操作和監管基礎進行全面概述。

本執行摘要詳細分析了傳統髖螺釘，整合了影響醫院採購和醫療設備應用的臨床趨勢、供應鏈發展和產品設計考量。引言部分概述了影響醫療醫療設備選擇的臨床需求，包括骨折類型處理、固定穩定性要求以及外科醫生基於解剖多樣性和患者合併症情況的偏好。透過闡明傳統髖螺釘在整形外科醫學中的現狀，本概要解釋了醫療設備設計、材料選擇和手術入路之間的相互聯繫，以及它們如何影響術中說明和術後結果。

技術進步、外科手術技術變革和供應鏈韌性如何重新定義髖關節植入的競爭格局和臨床應用？

傳統髖關節螺釘的市場格局正因技術進步、外科手術技術的提升以及相關人員期望的改變而重塑，這些變革正在影響採購決策和產品開發重點。植入冶金和生物可吸收複合材料的進步促使人們重新評估長期以來材料選擇上的權衡取捨，而鎖定介面和套管技術的改進則使外科醫生能夠在減少軟組織損傷的同時，採用更精準的固定策略。

為因應 2025 年實施的關稅措施，政策主導的採購審查和供應鏈調整正在推進，植入相關人員的供應商、定價結構和業務永續營運正在重組。

2025年關稅的引入和貿易政策的變化帶來了新的變數，將影響整形外科植入的製造策略、分銷經濟效益和臨床採購實踐。這些政策轉變迫使製造商重新評估籌資策略，一些製造商透過供應商多元化和生產線重組來降低關稅風險。因此，整個醫療保健系統的採購團隊都在日益關注總到岸成本以及集中採購模式與在地化採購模式之間的權衡取捨。

透過對臨床應用案例、醫療保健環境和產品架構進行策略性細分分析，確保醫療設備產品與採購重點的精準匹配。

對市場區隔的精準理解揭示了臨床需求、採購優先順序和產品設計之間的交集，從而明確了在應用、醫療環境、分銷模式、材料、手術方法和產品架構等方面的策略定位。單獨考慮應用時，產品環境可分為重組手術和創傷手術，二者分別對應不同的性能要求和器械需求。重組手術通常優先考慮長期固定和與人工關節重建的兼容性，而創傷手術則優先考慮快速穩定和在緊急情況下易於植入。

區域商業化需求和臨床應用模式指導著全球整形外科市場的分銷策略和外科培訓重點。

區域趨勢為供應鏈發展、臨床醫生培訓投資和監管合規提供了至關重要的背景信息，指明了製造商和經銷商應將商業化和營運資源集中於哪些領域。在美洲，醫療保健格局的特點是：大規模創傷中心網路廣泛分佈，擇期整形外科手術中微創技術應用普遍，以及採購環境成熟，強調臨床療效和治療總成本的證據。這種環境支持植入和服務模式，從而確保外科醫生能夠快速採用這些模式，並確保供應的可靠性和可預測性。

透過創新、臨床證據和供應彈性實現競爭定位，正在影響供應商的選擇和傳統髖關節螺釘系統的採用。

醫療設備製造商和供應商之間的競爭格局取決於技術差異化、臨床證據的累積以及提供全面服務包的能力，這些服務包能夠降低手術團隊採用產品的門檻。主要企業正投資於模組化系統和整合器械解決方案，以促進微創植入；而其他企業則強調產品組合的廣度，以支持重組外科和創傷適應症等各種不同的病例組合。製造商和分銷商之間的策略夥伴關係仍然是擴大市場滲透率的關鍵，尤其是在提供客製化培訓和術中植入交付計劃以支持外科醫生學習曲線的情況下。

醫療設備製造商和供應商可採取切實可行的策略措施，以加速器材普及、增強供應連續性，並使商業化與臨床工作流程保持一致。

產業領導企業應採取多管齊下的策略，將產品開發、商業策略和臨床醫生協作結合，以確保產品的永續應用和營運效率。優先事項應包括投資於以臨床醫生為中心的設計改進，以降低手術複雜性，並兼顧微創和開放式手術。這將擴大產品在所有創傷和重組適應症中的適用性。器械人體工學和手術專用工具包的配套投資將縮短學習曲線，減少手術時間，從而促進產品在高流量創傷中心和門診手術中心的應用。

為了確保獲得可靠和實用的見解，我們採用多層次的調查方法，結合與專家的直接對話、證據整合和跨部門檢驗。

本調查方法採用多層次整合策略，旨在產生可靠且可操作的洞見，並透過交叉檢驗多個資料流來驗證研究結果並減少偏差。關鍵的定性資料包括對骨科醫生、採購經理和分銷合作夥伴的結構化訪談，從而直接觀點臨床偏好、採購決策標準和物流限制。此外，也對醫療器材層面的技術審查和監管申報文件進行評估，從而深入了解產品設計選擇和上市後監測的考量。

在不斷發展的整形外科醫學領域，臨床、商業性和營運要求的整合決定了植入開發商和醫療保健採購商的成功。

總之，在臨床創新、手術技術現代化和外部經濟因素的複雜交互作用下，傳統髖關節螺釘的市場格局正在改變。人們對器械性能的期望不再局限於即時固定，而是包括能夠提高外科醫生效率、簡化器械操作以及幫助醫療機構實現品質和成本目標的可驗證療效。這些變化為製造商創造了新的機遇，他們可以將技術改進與有意義的證據和可擴展的商業模式相結合，從而滿足創傷中心、醫院、門診手術中心和專科診所的多樣化需求。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席主管觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 工業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 波特五力分析
  • PESTEL 分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

第8章 傳統髖關節螺絲市場：依產品類型分類

  • 中空髖關節螺絲
  • 動態髖關節螺絲系統
  • 鎖定式髖螺釘
  • 非中空、非鎖定式髖螺釘

第9章：傳統髖螺釘市場：依材料分類

  • 生物可吸收
  • 防鏽的
  • 鈦

第10章 傳統髖關節螺絲市場：依手術入路分類

  • 微創
  • 打開

第11章 傳統髖關節螺絲市場：依應用領域分類

  • 重組手術
  • 創傷

第12章 傳統髖螺絲市場：依最終用戶分類

  • 門診手術中心
  • 醫院
  • 整形外科診所
  • 創傷中心

第13章：傳統髖螺絲市場：依通路分類

  • 直銷
  • 銷售代理

第14章 傳統髖關節螺絲市場：依地區分類

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第15章 傳統髖螺絲市場：依組別分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第16章 傳統髖螺絲市場：依國家分類

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第17章：美國傳統髖關節螺絲市場

第18章：中國傳統髖關節螺絲市場

第19章 競爭情勢

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年
  • Acumed LLC
  • Altius Healthcare Ltd.
  • Arthrex, Inc.
  • B. Braun Melsungen AG
  • BioTek Instruments, Inc.
  • CONMED Corporation
  • DJO Global, Inc.
  • Exactech, Inc.
  • FH Orthopedics
  • Globus Medical, Inc.
  • Integra LifeSciences Corporation
  • KLS Martin Group
  • Life Spine, Inc.
  • Limacorporate SpA
  • Medtronic plc
  • MicroPort Scientific Corporation
  • NuVasive, Inc.
  • Orthofix Medical Inc.
  • Smith & Nephew plc
  • Stryker Corporation
  • Waston Medical Corporation
  • Wright Medical Group NV
  • Zimmer Biomet Holdings, Inc.
Product Code: MRR-3A68B83977E6

The Conventional Hip Screws Market was valued at USD 446.60 million in 2025 and is projected to grow to USD 469.95 million in 2026, with a CAGR of 5.85%, reaching USD 664.95 million by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 446.60 million
Estimated Year [2026] USD 469.95 million
Forecast Year [2032] USD 664.95 million
CAGR (%) 5.85%

Comprehensive orientation to clinical, operational, and regulatory fundamentals that define contemporary conventional hip screw utilization across surgical practice

This executive summary introduces a rigorous analysis of conventional hip screws, synthesizing clinical trends, supply chain dynamics, and product architecture considerations that influence hospital procurement and device adoption. The introduction frames the clinical imperatives driving device selection, including fracture pattern management, fixation stability requirements, and surgeon preferences linked to anatomical variability and patient comorbidity profiles. By contextualizing conventional hip screws within current orthopaedic practice, the narrative clarifies how device design, material choice, and surgical approach intersect to affect intraoperative decision-making and postoperative outcomes.

Transitioning from clinical need to commercial context, the introduction also outlines the technological lineage of hip screw devices and the contemporary focus on minimally invasive techniques, locking mechanisms, and material innovations intended to optimize healing biomechanics. Moreover, regulatory and reimbursement environments continue to shape product lifecycle strategies, with post-market surveillance and real-world evidence becoming increasingly central to device differentiation. This section establishes the foundational concepts and evaluation criteria that underpin subsequent analysis, ensuring readers possess the clinical, operational, and regulatory perspective needed to interpret segmentation, regional patterns, and implications for manufacturing and distribution partners.

Finally, the introduction sets expectations for the report's methodology and the granularity of insights, clarifying that the emphasis is on actionable intelligence for stakeholders ranging from clinical adoption committees to commercial strategy teams. It positions the report as a practical instrument to refine product portfolios, inform hospital purchase protocols, and guide engagement with surgeons and procurement officers in diverse care settings.

How technological advances, procedural shifts, and supply chain resilience are collectively redefining competitive dynamics and clinical adoption of hip screw implants

The landscape for conventional hip screws is being reshaped by a confluence of technological refinement, procedural evolution, and shifting stakeholder expectations, producing transformative shifts that will influence procurement decisions and product development priorities. Advances in implant metallurgy and bioabsorbable composites are prompting reevaluation of long-standing material trade-offs, while improvements in locking interfaces and cannulation techniques are enabling surgeons to pursue more precise fixation strategies with reduced soft-tissue disruption.

Concurrently, procedural trends toward minimally invasive approaches are altering instrumentation requirements and operating room workflows, amplifying demand for devices and kits that simplify percutaneous placement while maintaining biomechanical integrity. At the same time, supply chain resilience and nearshoring considerations are prompting manufacturers and distributors to reassess distribution footprints and contractual frameworks, seeking to reduce lead times and ensure sterile implant availability for high-acuity trauma caseloads.

Clinically, heightened emphasis on patient-reported outcomes and the integration of data from registries and electronic health records are enabling more granular comparative assessments of implant performance over the care continuum. These data-driven insights are reinforcing preferences for implants that demonstrably reduce reoperation rates and support rehabilitation protocols. From a commercial vantage point, the interplay of these trends fosters opportunities for device differentiation through modular implant systems, procedure-specific instrumentation, and enhanced training programs designed to accelerate surgeon competency with new approaches. Taken together, these shifts create a dynamic environment in which agility and evidence-based positioning are essential for sustained relevance.

Policy-driven procurement recalibration and supply chain adaptation in response to 2025 tariffs reshaping sourcing, pricing structures, and operational continuity for implant stakeholders

The implementation of tariffs and trade policy changes in 2025 has introduced new variables that reverberate through manufacturing strategies, distribution economics, and clinical procurement practices for orthopaedic implants. These policy shifts have prompted manufacturers to reassess sourcing strategies for raw materials and subcomponents, particularly for stainless steel and titanium alloys, leading some producers to diversify suppliers and reconfigure production lines to mitigate tariff exposure. As a result, procurement teams across health systems are increasingly scrutinizing total landed costs and the trade-offs associated with centralized versus localized sourcing models.

Beyond supplier reconfiguration, the tariff environment has stimulated more active collaboration between manufacturers and distributors to explore pricing structures, consignment options, and value-based contracting to preserve access to essential implants in high-volume trauma centers and reconstructive programs. Hospitals and ambulatory surgical centers are responding by strengthening strategic relationships with trusted suppliers and by adopting more rigorous purchase agreement terms that account for tariff-driven volatility. This environment has also spurred conversations about inventory management, with greater attention to buffer stock strategies and working capital implications for smaller orthopedic clinics and ambulatory surgical centers.

From an innovation perspective, some manufacturers are revisiting material substitutions and manufacturing efficiencies to contain cost impacts while preserving clinical performance. This realignment underscores the importance of flexible commercial models and proactive policy monitoring by stakeholders across the implant value chain, so that clinical continuity and patient care pathways remain robust despite evolving trade constraints.

Strategic segmentation analysis aligning clinical use cases, care settings, and product architectures to enable precise alignment of device offerings and procurement priorities

A nuanced understanding of segmentation illuminates where clinical demand, procurement priorities, and product design intersect, providing clarity for strategic positioning across applications, care settings, distribution models, materials, surgical approaches, and product architectures. When examined by application, the product landscape bifurcates between reconstructive surgery and trauma, each driving distinct performance profiles and instrumentation needs; reconstructive procedures often emphasize long-term fixation and compatibility with arthroplasty pathways, whereas trauma applications prioritize rapid stability and ease of insertion in emergent contexts.

End user segmentation further differentiates demand patterns across ambulatory surgical centers, hospitals, orthopedic clinics, and trauma centers, reflecting variation in case complexity, inventory capacity, and procedural throughput. Distribution channel dynamics break down into direct sales and distributors, with direct relationships favoring tailored training and bundled services, while distributor networks offer reach and logistical scalability. Material segmentation-spanning bioabsorbable options, stainless steel, and titanium-shapes both clinical handling and regulatory pathways, and influences sterilization practices, imaging artifact considerations, and long-term biocompatibility discussions.

Surgical approach segmentation contrasts minimally invasive and open techniques, driving divergent instrument sets and implant geometries that can alter OR time and postoperative recovery trajectories. Product-type segmentation captures the diversity of device families, encompassing cannulated hip screws, dynamic hip screw systems, locking hip screws, and non-cannulated nonlocking hip screws. Within these families there are important sub-classifications: cannulated hip screws are distinguished by screw diameter, commonly categorized across diameters such as 6.5 mm, 7.3 mm, and 8.0 mm; dynamic hip screw systems differentiate by plate type, including single-barrel and double-barrel configurations; locking hip screws are defined by screw type, such as locking cannulated and locking head variants; and non-cannulated nonlocking hip screws are segmented by screw size into large, medium, and small. Collectively, these segmentation lenses permit precise alignment of product offerings with clinical protocols and institutional purchasing strategies, enabling manufacturers and providers to optimize inventories and training programs according to procedural mix and surgeon preference.

Regional commercialization imperatives and clinical adoption patterns guiding distribution strategies and surgeon training priorities across global orthopaedic landscapes

Regional dynamics impart important context for supply chain configuration, clinician training investments, and regulatory navigation, informing where manufacturers and distributors should concentrate commercialization and operational resources. In the Americas, the healthcare environment is characterized by a broad network of high-volume trauma centers, widespread adoption of minimally invasive techniques in elective orthopedics, and a sophisticated procurement landscape that values evidence of clinical outcomes and total cost of care. These conditions favor implants and service models that support rapid surgeon adoption and predictable supply reliability.

Across Europe, the Middle East & Africa, regulatory heterogeneity and diverse hospital funding mechanisms necessitate adaptive market-entry strategies and flexible distribution partnerships. Nations within this region may prioritize different materials or procedural approaches based on reimbursement frameworks and surgical training norms, creating opportunities for targeted clinical education and localized inventory strategies. Meanwhile, Asia-Pacific presents a heterogeneous mix of high-growth urban centers with growing orthopedic procedural volumes alongside markets where access and infrastructure constraints influence device selection and distribution. Rapid expansion of ambulatory surgical centers and increasing investment in trauma care capacity in several Asia-Pacific countries create demand for implants that balance cost-effectiveness with reliable clinical performance.

Taken together, these regional distinctions underscore the importance of tailoring commercialization approaches to local regulatory environments, clinical practice patterns, and supply chain realities. Manufacturers that align distribution models, training programs, and product portfolios to regional priorities can better support surgeons and procurement teams in addressing both routine and complex fixation needs.

Competitive positioning through innovation, clinical evidence, and supply resilience shaping vendor preference and adoption of conventional hip screw systems

Competitive dynamics among device manufacturers and suppliers are shaped by technological differentiation, clinical evidence generation, and the ability to deliver comprehensive service packages that reduce adoption friction for surgical teams. Leading firms have invested in modular systems and integrated instrumentation solutions that facilitate minimally invasive placement, while others emphasize the breadth of their portfolio to support diverse case mixes across reconstructive and trauma indications. Strategic partnerships between manufacturers and distributors remain central to expanding reach, particularly when tailored training and implants-in-theatre programs are offered to support surgeon learning curves.

Innovation pathways are increasingly defined by iterative improvements in implant locking mechanisms, cannulation geometry, and plate design, with several companies also investing in enhanced packaging and kit optimization to streamline operating room logistics. Clinical evidence and registry data play a growing role in competitive positioning, as hospitals and procurement groups seek implants backed by robust real-world performance metrics. At the same time, nimble smaller manufacturers are finding opportunities by targeting niche clinical needs or offering specialized instrumentation that reduces procedural complexity.

Supply-side resilience is another competitive lever, with companies that can demonstrate reliable lead times, diversified manufacturing footprints, and responsive customer support gaining preference among institutional buyers. Additionally, firms that proactively engage clinicians through training programs, simulation, and outcomes collaboration are better positioned to influence long-term product selection and to integrate their implants into standardized care pathways.

Practical strategic moves for manufacturers and providers to accelerate device adoption, strengthen supply continuity, and align commercialization with clinical workflows

Industry leaders should pursue a multi-pronged approach that aligns product development, commercial strategy, and clinician engagement to secure sustainable adoption and operational efficiency. Priority actions include investing in clinician-centric design enhancements that reduce procedural complexity and accommodate both minimally invasive and open approaches, thereby expanding appeal across trauma and reconstructive indications. Complementary investments in instrumentation ergonomics and procedure-specific kits can shorten learning curves and reduce operating room time, supporting adoption among high-volume trauma centers and ambulatory surgical settings.

From a commercial perspective, developing flexible distribution arrangements that blend direct sales for high-touch accounts with distributor partnerships for broader geographic reach can improve market access while preserving opportunities for clinical training and bundled solutions. Manufacturers should also consider targeted regional strategies that respond to regulatory nuances and procurement modalities, prioritizing supply chain resilience in regions where tariff exposure or logistical constraints present risks. In parallel, building a compelling value story through clinical evidence, registry participation, and surgeon outcomes partnerships will strengthen dialogue with hospital committees and procurement teams.

Finally, collaboration between manufacturers, distributors, and clinical leaders to design inventory models, consignment programs, and educational initiatives can reduce adoption barriers for smaller orthopedic clinics and ambulatory surgical centers. Emphasizing transparency in total acquisition costs, operational benefits, and patient-centered outcomes will better equip decision-makers to evaluate device options in a resource-constrained environment.

Layered methodological framework combining primary expert engagement, evidence synthesis, and cross-functional validation to ensure credible actionable insights

The research methodology integrates a layered approach designed to produce robust, actionable insights while triangulating across multiple data streams to verify findings and reduce bias. Primary qualitative inputs include structured interviews with orthopedic surgeons, procurement leaders, and distribution partners, offering direct perspectives on clinical preferences, purchasing decision criteria, and logistical constraints. These interviews are supplemented with device-level technical reviews and an assessment of regulatory filings to contextualize product design choices and post-market surveillance considerations.

Secondary research was conducted by reviewing peer-reviewed clinical literature, procedural guidelines, and public regulatory documentation to ground clinical assertions in evidence. In addition, supply chain and policy analyses were performed to evaluate the operational implications of tariffs, trade policy changes, and manufacturing footprint strategies. Synthesis of these inputs was organized around the segmentation framework covering application, end user, distribution channel, material, surgical approach, and product type, enabling cross-cutting analysis of how clinical needs and commercial realities intersect.

Analytical rigor was maintained through iterative validation workshops with clinical and industry experts, ensuring that interpretations were consistent with frontline practice. Where appropriate, sensitivity checks were applied to qualitative findings to surface alternative explanations and to highlight areas requiring additional data collection or targeted field research. The combination of primary stakeholder engagement, evidence review, and cross-functional validation supports the credibility and practical utility of the conclusions and recommendations presented in this report.

Synthesis of clinical, commercial, and operational imperatives that define success for implant developers and institutional buyers in evolving orthopaedic care

In conclusion, the conventional hip screw landscape is evolving under the combined influence of clinical innovation, procedural modernisation, and external economic drivers. Device performance expectations now extend beyond immediate fixation to encompass surgeon ergonomics, streamlined instrumentation, and demonstrable outcomes that support institutional quality and cost objectives. These changes create opportunities for manufacturers that can marry technical improvements with meaningful evidence and scalable commercial models that address the diverse needs of trauma centers, hospitals, ambulatory surgical centers, and specialty clinics.

At the same time, supply chain and policy developments underscore the necessity of resilient sourcing strategies and flexible distribution architectures to maintain clinical continuity. Regional dynamics further emphasize the need to tailor product portfolios and engagement programs to local regulations, training ecosystems, and procurement modalities. For clinical leaders and purchasing decision-makers, the pathway forward involves prioritizing implants that align with procedural mixes, surgeon preferences, and institutional capacity to support inventory and training investments.

Ultimately, organizations that integrate clinician-focused design, evidence-driven value propositions, and adaptive commercial approaches will be best positioned to meet evolving clinical demands while safeguarding operational resilience. This report serves as a practical guide for stakeholders seeking to refine product strategies, strengthen supply relationships, and optimize clinical adoption of conventional hip screw systems.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Conventional Hip Screws Market, by Product Type

  • 8.1. Cannulated Hip Screws
  • 8.2. Dynamic Hip Screw Systems
  • 8.3. Locking Hip Screws
  • 8.4. Non-Cannulated Nonlocking Hip Screws

9. Conventional Hip Screws Market, by Material

  • 9.1. Bioabsorbable
  • 9.2. Stainless Steel
  • 9.3. Titanium

10. Conventional Hip Screws Market, by Surgical Approach

  • 10.1. Minimally Invasive
  • 10.2. Open

11. Conventional Hip Screws Market, by Application

  • 11.1. Reconstructive Surgery
  • 11.2. Trauma

12. Conventional Hip Screws Market, by End User

  • 12.1. Ambulatory Surgical Centers
  • 12.2. Hospitals
  • 12.3. Orthopedic Clinics
  • 12.4. Trauma Centers

13. Conventional Hip Screws Market, by Distribution Channel

  • 13.1. Direct Sales
  • 13.2. Distributors

14. Conventional Hip Screws Market, by Region

  • 14.1. Americas
    • 14.1.1. North America
    • 14.1.2. Latin America
  • 14.2. Europe, Middle East & Africa
    • 14.2.1. Europe
    • 14.2.2. Middle East
    • 14.2.3. Africa
  • 14.3. Asia-Pacific

15. Conventional Hip Screws Market, by Group

  • 15.1. ASEAN
  • 15.2. GCC
  • 15.3. European Union
  • 15.4. BRICS
  • 15.5. G7
  • 15.6. NATO

16. Conventional Hip Screws Market, by Country

  • 16.1. United States
  • 16.2. Canada
  • 16.3. Mexico
  • 16.4. Brazil
  • 16.5. United Kingdom
  • 16.6. Germany
  • 16.7. France
  • 16.8. Russia
  • 16.9. Italy
  • 16.10. Spain
  • 16.11. China
  • 16.12. India
  • 16.13. Japan
  • 16.14. Australia
  • 16.15. South Korea

17. United States Conventional Hip Screws Market

18. China Conventional Hip Screws Market

19. Competitive Landscape

  • 19.1. Market Concentration Analysis, 2025
    • 19.1.1. Concentration Ratio (CR)
    • 19.1.2. Herfindahl Hirschman Index (HHI)
  • 19.2. Recent Developments & Impact Analysis, 2025
  • 19.3. Product Portfolio Analysis, 2025
  • 19.4. Benchmarking Analysis, 2025
  • 19.5. Acumed LLC
  • 19.6. Altius Healthcare Ltd.
  • 19.7. Arthrex, Inc.
  • 19.8. B. Braun Melsungen AG
  • 19.9. BioTek Instruments, Inc.
  • 19.10. CONMED Corporation
  • 19.11. DJO Global, Inc.
  • 19.12. Exactech, Inc.
  • 19.13. FH Orthopedics
  • 19.14. Globus Medical, Inc.
  • 19.15. Integra LifeSciences Corporation
  • 19.16. KLS Martin Group
  • 19.17. Life Spine, Inc.
  • 19.18. Limacorporate S.p.A.
  • 19.19. Medtronic plc
  • 19.20. MicroPort Scientific Corporation
  • 19.21. NuVasive, Inc.
  • 19.22. Orthofix Medical Inc.
  • 19.23. Smith & Nephew plc
  • 19.24. Stryker Corporation
  • 19.25. Waston Medical Corporation
  • 19.26. Wright Medical Group N.V.
  • 19.27. Zimmer Biomet Holdings, Inc.

LIST OF FIGURES

  • FIGURE 1. GLOBAL CONVENTIONAL HIP SCREWS MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL CONVENTIONAL HIP SCREWS MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL CONVENTIONAL HIP SCREWS MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL CONVENTIONAL HIP SCREWS MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL CONVENTIONAL HIP SCREWS MARKET SIZE, BY MATERIAL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL CONVENTIONAL HIP SCREWS MARKET SIZE, BY SURGICAL APPROACH, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL CONVENTIONAL HIP SCREWS MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL CONVENTIONAL HIP SCREWS MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL CONVENTIONAL HIP SCREWS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL CONVENTIONAL HIP SCREWS MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. GLOBAL CONVENTIONAL HIP SCREWS MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL CONVENTIONAL HIP SCREWS MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 13. UNITED STATES CONVENTIONAL HIP SCREWS MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 14. CHINA CONVENTIONAL HIP SCREWS MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL CONVENTIONAL HIP SCREWS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL CONVENTIONAL HIP SCREWS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL CONVENTIONAL HIP SCREWS MARKET SIZE, BY CANNULATED HIP SCREWS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL CONVENTIONAL HIP SCREWS MARKET SIZE, BY CANNULATED HIP SCREWS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL CONVENTIONAL HIP SCREWS MARKET SIZE, BY CANNULATED HIP SCREWS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL CONVENTIONAL HIP SCREWS MARKET SIZE, BY DYNAMIC HIP SCREW SYSTEMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL CONVENTIONAL HIP SCREWS MARKET SIZE, BY DYNAMIC HIP SCREW SYSTEMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL CONVENTIONAL HIP SCREWS MARKET SIZE, BY DYNAMIC HIP SCREW SYSTEMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL CONVENTIONAL HIP SCREWS MARKET SIZE, BY LOCKING HIP SCREWS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL CONVENTIONAL HIP SCREWS MARKET SIZE, BY LOCKING HIP SCREWS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL CONVENTIONAL HIP SCREWS MARKET SIZE, BY LOCKING HIP SCREWS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL CONVENTIONAL HIP SCREWS MARKET SIZE, BY NON-CANNULATED NONLOCKING HIP SCREWS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL CONVENTIONAL HIP SCREWS MARKET SIZE, BY NON-CANNULATED NONLOCKING HIP SCREWS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL CONVENTIONAL HIP SCREWS MARKET SIZE, BY NON-CANNULATED NONLOCKING HIP SCREWS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL CONVENTIONAL HIP SCREWS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL CONVENTIONAL HIP SCREWS MARKET SIZE, BY BIOABSORBABLE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL CONVENTIONAL HIP SCREWS MARKET SIZE, BY BIOABSORBABLE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL CONVENTIONAL HIP SCREWS MARKET SIZE, BY BIOABSORBABLE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL CONVENTIONAL HIP SCREWS MARKET SIZE, BY STAINLESS STEEL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL CONVENTIONAL HIP SCREWS MARKET SIZE, BY STAINLESS STEEL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL CONVENTIONAL HIP SCREWS MARKET SIZE, BY STAINLESS STEEL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL CONVENTIONAL HIP SCREWS MARKET SIZE, BY TITANIUM, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL CONVENTIONAL HIP SCREWS MARKET SIZE, BY TITANIUM, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL CONVENTIONAL HIP SCREWS MARKET SIZE, BY TITANIUM, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL CONVENTIONAL HIP SCREWS MARKET SIZE, BY SURGICAL APPROACH, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL CONVENTIONAL HIP SCREWS MARKET SIZE, BY MINIMALLY INVASIVE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL CONVENTIONAL HIP SCREWS MARKET SIZE, BY MINIMALLY INVASIVE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL CONVENTIONAL HIP SCREWS MARKET SIZE, BY MINIMALLY INVASIVE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL CONVENTIONAL HIP SCREWS MARKET SIZE, BY OPEN, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL CONVENTIONAL HIP SCREWS MARKET SIZE, BY OPEN, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL CONVENTIONAL HIP SCREWS MARKET SIZE, BY OPEN, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL CONVENTIONAL HIP SCREWS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL CONVENTIONAL HIP SCREWS MARKET SIZE, BY RECONSTRUCTIVE SURGERY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL CONVENTIONAL HIP SCREWS MARKET SIZE, BY RECONSTRUCTIVE SURGERY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL CONVENTIONAL HIP SCREWS MARKET SIZE, BY RECONSTRUCTIVE SURGERY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL CONVENTIONAL HIP SCREWS MARKET SIZE, BY TRAUMA, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL CONVENTIONAL HIP SCREWS MARKET SIZE, BY TRAUMA, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL CONVENTIONAL HIP SCREWS MARKET SIZE, BY TRAUMA, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL CONVENTIONAL HIP SCREWS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL CONVENTIONAL HIP SCREWS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL CONVENTIONAL HIP SCREWS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL CONVENTIONAL HIP SCREWS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL CONVENTIONAL HIP SCREWS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL CONVENTIONAL HIP SCREWS MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL CONVENTIONAL HIP SCREWS MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL CONVENTIONAL HIP SCREWS MARKET SIZE, BY ORTHOPEDIC CLINICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL CONVENTIONAL HIP SCREWS MARKET SIZE, BY ORTHOPEDIC CLINICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL CONVENTIONAL HIP SCREWS MARKET SIZE, BY ORTHOPEDIC CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL CONVENTIONAL HIP SCREWS MARKET SIZE, BY TRAUMA CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL CONVENTIONAL HIP SCREWS MARKET SIZE, BY TRAUMA CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL CONVENTIONAL HIP SCREWS MARKET SIZE, BY TRAUMA CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL CONVENTIONAL HIP SCREWS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL CONVENTIONAL HIP SCREWS MARKET SIZE, BY DIRECT SALES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL CONVENTIONAL HIP SCREWS MARKET SIZE, BY DIRECT SALES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL CONVENTIONAL HIP SCREWS MARKET SIZE, BY DIRECT SALES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL CONVENTIONAL HIP SCREWS MARKET SIZE, BY DISTRIBUTORS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL CONVENTIONAL HIP SCREWS MARKET SIZE, BY DISTRIBUTORS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL CONVENTIONAL HIP SCREWS MARKET SIZE, BY DISTRIBUTORS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL CONVENTIONAL HIP SCREWS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 60. AMERICAS CONVENTIONAL HIP SCREWS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 61. AMERICAS CONVENTIONAL HIP SCREWS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 62. AMERICAS CONVENTIONAL HIP SCREWS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 63. AMERICAS CONVENTIONAL HIP SCREWS MARKET SIZE, BY SURGICAL APPROACH, 2018-2032 (USD MILLION)
  • TABLE 64. AMERICAS CONVENTIONAL HIP SCREWS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 65. AMERICAS CONVENTIONAL HIP SCREWS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 66. AMERICAS CONVENTIONAL HIP SCREWS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 67. NORTH AMERICA CONVENTIONAL HIP SCREWS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 68. NORTH AMERICA CONVENTIONAL HIP SCREWS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 69. NORTH AMERICA CONVENTIONAL HIP SCREWS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 70. NORTH AMERICA CONVENTIONAL HIP SCREWS MARKET SIZE, BY SURGICAL APPROACH, 2018-2032 (USD MILLION)
  • TABLE 71. NORTH AMERICA CONVENTIONAL HIP SCREWS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 72. NORTH AMERICA CONVENTIONAL HIP SCREWS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 73. NORTH AMERICA CONVENTIONAL HIP SCREWS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 74. LATIN AMERICA CONVENTIONAL HIP SCREWS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 75. LATIN AMERICA CONVENTIONAL HIP SCREWS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 76. LATIN AMERICA CONVENTIONAL HIP SCREWS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 77. LATIN AMERICA CONVENTIONAL HIP SCREWS MARKET SIZE, BY SURGICAL APPROACH, 2018-2032 (USD MILLION)
  • TABLE 78. LATIN AMERICA CONVENTIONAL HIP SCREWS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 79. LATIN AMERICA CONVENTIONAL HIP SCREWS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 80. LATIN AMERICA CONVENTIONAL HIP SCREWS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 81. EUROPE, MIDDLE EAST & AFRICA CONVENTIONAL HIP SCREWS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 82. EUROPE, MIDDLE EAST & AFRICA CONVENTIONAL HIP SCREWS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 83. EUROPE, MIDDLE EAST & AFRICA CONVENTIONAL HIP SCREWS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 84. EUROPE, MIDDLE EAST & AFRICA CONVENTIONAL HIP SCREWS MARKET SIZE, BY SURGICAL APPROACH, 2018-2032 (USD MILLION)
  • TABLE 85. EUROPE, MIDDLE EAST & AFRICA CONVENTIONAL HIP SCREWS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 86. EUROPE, MIDDLE EAST & AFRICA CONVENTIONAL HIP SCREWS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 87. EUROPE, MIDDLE EAST & AFRICA CONVENTIONAL HIP SCREWS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 88. EUROPE CONVENTIONAL HIP SCREWS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 89. EUROPE CONVENTIONAL HIP SCREWS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 90. EUROPE CONVENTIONAL HIP SCREWS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 91. EUROPE CONVENTIONAL HIP SCREWS MARKET SIZE, BY SURGICAL APPROACH, 2018-2032 (USD MILLION)
  • TABLE 92. EUROPE CONVENTIONAL HIP SCREWS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 93. EUROPE CONVENTIONAL HIP SCREWS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 94. EUROPE CONVENTIONAL HIP SCREWS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 95. MIDDLE EAST CONVENTIONAL HIP SCREWS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 96. MIDDLE EAST CONVENTIONAL HIP SCREWS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 97. MIDDLE EAST CONVENTIONAL HIP SCREWS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 98. MIDDLE EAST CONVENTIONAL HIP SCREWS MARKET SIZE, BY SURGICAL APPROACH, 2018-2032 (USD MILLION)
  • TABLE 99. MIDDLE EAST CONVENTIONAL HIP SCREWS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 100. MIDDLE EAST CONVENTIONAL HIP SCREWS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 101. MIDDLE EAST CONVENTIONAL HIP SCREWS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 102. AFRICA CONVENTIONAL HIP SCREWS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 103. AFRICA CONVENTIONAL HIP SCREWS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 104. AFRICA CONVENTIONAL HIP SCREWS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 105. AFRICA CONVENTIONAL HIP SCREWS MARKET SIZE, BY SURGICAL APPROACH, 2018-2032 (USD MILLION)
  • TABLE 106. AFRICA CONVENTIONAL HIP SCREWS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 107. AFRICA CONVENTIONAL HIP SCREWS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 108. AFRICA CONVENTIONAL HIP SCREWS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 109. ASIA-PACIFIC CONVENTIONAL HIP SCREWS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 110. ASIA-PACIFIC CONVENTIONAL HIP SCREWS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 111. ASIA-PACIFIC CONVENTIONAL HIP SCREWS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 112. ASIA-PACIFIC CONVENTIONAL HIP SCREWS MARKET SIZE, BY SURGICAL APPROACH, 2018-2032 (USD MILLION)
  • TABLE 113. ASIA-PACIFIC CONVENTIONAL HIP SCREWS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 114. ASIA-PACIFIC CONVENTIONAL HIP SCREWS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 115. ASIA-PACIFIC CONVENTIONAL HIP SCREWS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 116. GLOBAL CONVENTIONAL HIP SCREWS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 117. ASEAN CONVENTIONAL HIP SCREWS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 118. ASEAN CONVENTIONAL HIP SCREWS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 119. ASEAN CONVENTIONAL HIP SCREWS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 120. ASEAN CONVENTIONAL HIP SCREWS MARKET SIZE, BY SURGICAL APPROACH, 2018-2032 (USD MILLION)
  • TABLE 121. ASEAN CONVENTIONAL HIP SCREWS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 122. ASEAN CONVENTIONAL HIP SCREWS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 123. ASEAN CONVENTIONAL HIP SCREWS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 124. GCC CONVENTIONAL HIP SCREWS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 125. GCC CONVENTIONAL HIP SCREWS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 126. GCC CONVENTIONAL HIP SCREWS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 127. GCC CONVENTIONAL HIP SCREWS MARKET SIZE, BY SURGICAL APPROACH, 2018-2032 (USD MILLION)
  • TABLE 128. GCC CONVENTIONAL HIP SCREWS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 129. GCC CONVENTIONAL HIP SCREWS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 130. GCC CONVENTIONAL HIP SCREWS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 131. EUROPEAN UNION CONVENTIONAL HIP SCREWS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 132. EUROPEAN UNION CONVENTIONAL HIP SCREWS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 133. EUROPEAN UNION CONVENTIONAL HIP SCREWS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 134. EUROPEAN UNION CONVENTIONAL HIP SCREWS MARKET SIZE, BY SURGICAL APPROACH, 2018-2032 (USD MILLION)
  • TABLE 135. EUROPEAN UNION CONVENTIONAL HIP SCREWS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 136. EUROPEAN UNION CONVENTIONAL HIP SCREWS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 137. EUROPEAN UNION CONVENTIONAL HIP SCREWS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 138. BRICS CONVENTIONAL HIP SCREWS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 139. BRICS CONVENTIONAL HIP SCREWS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 140. BRICS CONVENTIONAL HIP SCREWS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 141. BRICS CONVENTIONAL HIP SCREWS MARKET SIZE, BY SURGICAL APPROACH, 2018-2032 (USD MILLION)
  • TABLE 142. BRICS CONVENTIONAL HIP SCREWS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 143. BRICS CONVENTIONAL HIP SCREWS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 144. BRICS CONVENTIONAL HIP SCREWS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 145. G7 CONVENTIONAL HIP SCREWS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 146. G7 CONVENTIONAL HIP SCREWS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 147. G7 CONVENTIONAL HIP SCREWS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 148. G7 CONVENTIONAL HIP SCREWS MARKET SIZE, BY SURGICAL APPROACH, 2018-2032 (USD MILLION)
  • TABLE 149. G7 CONVENTIONAL HIP SCREWS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 150. G7 CONVENTIONAL HIP SCREWS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 151. G7 CONVENTIONAL HIP SCREWS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 152. NATO CONVENTIONAL HIP SCREWS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 153. NATO CONVENTIONAL HIP SCREWS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 154. NATO CONVENTIONAL HIP SCREWS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 155. NATO CONVENTIONAL HIP SCREWS MARKET SIZE, BY SURGICAL APPROACH, 2018-2032 (USD MILLION)
  • TABLE 156. NATO CONVENTIONAL HIP SCREWS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 157. NATO CONVENTIONAL HIP SCREWS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 158. NATO CONVENTIONAL HIP SCREWS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 159. GLOBAL CONVENTIONAL HIP SCREWS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 160. UNITED STATES CONVENTIONAL HIP SCREWS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 161. UNITED STATES CONVENTIONAL HIP SCREWS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 162. UNITED STATES CONVENTIONAL HIP SCREWS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 163. UNITED STATES CONVENTIONAL HIP SCREWS MARKET SIZE, BY SURGICAL APPROACH, 2018-2032 (USD MILLION)
  • TABLE 164. UNITED STATES CONVENTIONAL HIP SCREWS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 165. UNITED STATES CONVENTIONAL HIP SCREWS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 166. UNITED STATES CONVENTIONAL HIP SCREWS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 167. CHINA CONVENTIONAL HIP SCREWS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 168. CHINA CONVENTIONAL HIP SCREWS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 169. CHINA CONVENTIONAL HIP SCREWS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 170. CHINA CONVENTIONAL HIP SCREWS MARKET SIZE, BY SURGICAL APPROACH, 2018-2032 (USD MILLION)
  • TABLE 171. CHINA CONVENTIONAL HIP SCREWS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 172. CHINA CONVENTIONAL HIP SCREWS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 173. CHINA CONVENTIONAL HIP SCREWS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)